The Valley Desk

LetterJournal of the European Academy of Dermatology and Venereology : JEADVPublished

Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Letter
Venue
Journal of the European Academy of Dermatology and Venereology : JEADV
Published
Subject terms
Humans; Psoriasis; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Antibodies, Monoclonal, Humanized; Adalimumab
PubMed ID
37415560
Added to directory
Source checked

Report a correction or request removal